Progyny, Inc.

NASDAQ:PGNY

22 (USD) • At close May 12, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Revenue 324.038298.431286.625304.087278.078269.94280.891279.373258.394214.321205.371195.004172.217127.553122.284128.651122.133100.30198.92864.60581.02465.12261.19656.16847.19729.18727.79826.15722.258
Cost of Revenue 248.243234.999227.381235.806215.672213.046218.267218.732199.754169.827159.376151.117139.268102.43893.79299.0393.22679.63578.09252.6564.42253.35348.87644.71637.23323.77222.75121.11918.324
Gross Profit 75.79563.43259.24468.28162.40656.89462.62460.64158.6444.49445.99543.88732.94925.11528.49229.62128.90720.66620.83611.95516.60211.76912.3211.4529.9645.4155.0475.0383.934
Gross Profit Ratio 0.2340.2130.2070.2250.2240.2110.2230.2170.2270.2080.2240.2250.1910.1970.2330.230.2370.2060.2110.1850.2050.1810.2010.2040.2110.1860.1820.1930.177
Reseach & Development Expenses 00000000000000000000000000000
General & Administrative Expenses 33.83932.02930.32931.17328.42928.18329.52430.07329.34728.20823.57423.55322.99217.60714.98613.93713.08614.72912.1210.1679.4767.376.0685.9814.5083.9753.9863.6243.794
Selling & Marketing Expenses 17.78615.61616.45716.42115.45414.91114.91115.38414.28212.9811.16611.49610.0157.6964.4414.0284.0144.7763.3553.6083.2673.2553.1833.1172.3462.1431.6481.7311.763
SG&A 51.62547.64546.78647.59443.88343.09444.43545.45743.62941.18834.7435.04933.00725.30319.42717.96517.119.50515.47513.77512.74310.6259.2519.0986.8546.1185.6345.3555.779
Other Expenses 00003.361.721.7081.2770.4980.2750.0820.025-0.096-0.293-0.0920.0120.0070.0320.0110.0030.16400000000
Operating Expenses 51.62547.64546.78647.59443.88343.09444.43545.45743.62941.18834.7435.04933.00725.30319.42717.96517.119.50515.47513.77512.74310.6259.2519.0986.8546.1185.6345.8145.963
Operating Income 24.1715.78712.45820.68718.52313.818.18915.18415.0113.30611.2558.838-0.058-0.1889.06511.65611.8071.1615.361-1.823.8591.1443.0692.3543.11-0.703-0.587-0.317-1.845
Operating Income Ratio 0.0750.0530.0430.0680.0670.0510.0650.0540.0580.0150.0550.045-0-0.0010.0740.0910.0970.0120.054-0.0280.0480.0180.050.0420.066-0.024-0.021-0.012-0.083
Total Other Income Expenses Net 2.3671.8715.5044.383.9922.4622.7421.9831.320.8350.2840.065-0.084-0.210.0520.264-0.0110.015-0.0060.0080.314-5.621-11.254-0.77-0.589-1.421-0.945-0.803-0.272
Income Before Tax 26.53717.65817.96225.06722.51516.26220.93117.16716.3314.14111.5398.903-0.142-0.3989.11711.9211.7961.1765.355-1.8124.173-4.477-8.1851.5842.521-2.124-1.532-1.12-2.117
Income Before Tax Ratio 0.0820.0590.0630.0820.0810.060.0750.0610.0630.0190.0560.046-0.001-0.0030.0750.0930.0970.0120.054-0.0280.052-0.069-0.1340.0280.053-0.073-0.055-0.043-0.095
Income Tax Expense 11.4787.1267.5418.5825.6172.7925.0332.176-1.3470.733-1.6720.135-5.113-15.478-7.679-6.807-3.37-37.8960.017-0.0050.116-0.0770.0250.0640.589-0.547-0.3950.2890.546
Net Income 15.05910.53210.42116.48516.89813.4715.89814.99117.6783.40813.2118.7684.97115.0816.79618.72715.16639.0725.355-1.8124.057-4.4-8.211.522.521-1.525-1.136-0.831-1.571
Net Income Ratio 0.0460.0350.0360.0540.0610.050.0570.0540.0680.0160.0640.0450.0290.1180.1370.1460.1240.390.054-0.0280.05-0.068-0.1340.0270.053-0.052-0.041-0.032-0.071
EPS 0.180.120.120.180.180.140.170.160.190.0370.140.090.050.170.190.210.170.450.06-0.0210.05-0.069-0.10.0220-0.022-0.016-0.15-0.28
EPS Diluted 0.170.120.110.170.170.130.160.150.180.0340.130.0880.050.150.170.190.150.390.05-0.0210.04-0.069-0.10.0190-0.022-0.014-0.15-0.28
EBITDA 24.1716.65512.45821.44119.23914.43418.76815.71115.5523.75211.669.2240.3060.1289.33211.95212.2291.6255.823-0.6124.3791.6833.6043.5453.62-0.215-0.1130.156-1.397
EBITDA Ratio 0.0750.0560.0430.0710.0690.0530.0670.0560.060.0180.0570.0470.0020.0010.0760.0930.10.0160.059-0.0090.0540.0260.0590.0630.077-0.007-0.0040.006-0.063